{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:51:36Z","timestamp":1790520696154,"version":"4.1.0"},"reference-count":202,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"NIH","award":["AI094474"],"award-info":[{"award-number":["AI094474"]}]},{"name":"NIH","award":["AI104636"],"award-info":[{"award-number":["AI104636"]}]},{"name":"NIH","award":["AI110762"],"award-info":[{"award-number":["AI110762"]}]},{"name":"NIH","award":["AI123271"],"award-info":[{"award-number":["AI123271"]}]},{"name":"NIH","award":["AI134818"],"award-info":[{"award-number":["AI134818"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.antiviral.2018.08.014","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T23:26:56Z","timestamp":1535066816000},"page":"185-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["Host functions used by hepatitis B virus to complete its life cycle: Implications for developing host-targeting agents to treat chronic hepatitis B"],"prefix":"10.1016","volume":"158","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6206-2723","authenticated-orcid":false,"given":"Bidisha","family":"Mitra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshan J.","family":"Thapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2018.08.014_bib203","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.3390\/v9060156","article-title":"The role of cccDNA in HBV maintenance","volume":"9","author":"Allweiss","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2018.08.014_bib204","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/hep.29509","article-title":"A research agenda for curing chronic hepatitis B virus infection","volume":"67","author":"Alter","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib1","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1128\/JVI.75.4.2024-2028.2001","article-title":"Does a cdc2 kinase-like recognition motif on the core protein of hepadnaviruses regulate assembly and disintegration of capsids?","volume":"75","author":"Barrasa","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib2","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2013.06.018","article-title":"Hepatitis B virus splicing is enhanced prior to development of hepatocellular carcinoma","volume":"59","author":"Bayliss","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib3","doi-asserted-by":"crossref","first-page":"19975","DOI":"10.1073\/pnas.0908365106","article-title":"Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function","volume":"106","author":"Belloni","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2018.08.014_bib4","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1172\/JCI58847","article-title":"IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome","volume":"122","author":"Belloni","year":"2012","journal-title":"JCI (J. Clin. Investig.)"},{"key":"10.1016\/j.antiviral.2018.08.014_bib5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7326\/0003-4819-150-2-200901200-00100","article-title":"National instittutes of health consensus development conference statement: management of hepatitis B","volume":"150","author":"Belongia","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.antiviral.2018.08.014_bib6","doi-asserted-by":"crossref","first-page":"12474","DOI":"10.1128\/JVI.05344-11","article-title":"Hepatocytes traffic and export hepatitis B virus basolaterally by polarity-dependent mechanisms","volume":"85","author":"Bhat","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib7","doi-asserted-by":"crossref","first-page":"11135","DOI":"10.1073\/pnas.0403925101","article-title":"Genomic DNA double-strand breaks are targets for hepadnaviral DNA integration","volume":"101","author":"Bill","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2018.08.014_bib8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jhep.2016.04.013","article-title":"First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B","volume":"65","author":"Blank","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/978-1-4615-5383-0_20","article-title":"Role of glycan processing in hepatitis B virus envelope protein trafficking","volume":"435","author":"Block","year":"1998","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib10","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1038\/sj.onc.1206557","article-title":"Molecular viral oncology of hepatocellular carcinoma","volume":"22","author":"Block","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.antiviral.2018.08.014_bib11","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.cld.2007.08.002","article-title":"Molecular virology of hepatitis B virus for clinicians","volume":"11","author":"Block","year":"2007","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.antiviral.2018.08.014_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.antiviral.2015.06.014","article-title":"Chronic hepatitis B: a wave of new therapies on the horizon","volume":"121","author":"Block","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.08.014_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF01703079","article-title":"Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell","volume":"8","author":"Bock","year":"1994","journal-title":"Virus Gene."},{"key":"10.1016\/j.antiviral.2018.08.014_bib14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/jmbi.2000.4481","article-title":"Structural organization of the hepatitis B virus minichromosome","volume":"307","author":"Bock","year":"2001","journal-title":"JMB (J. Mol. Biol.)"},{"key":"10.1016\/j.antiviral.2018.08.014_bib15","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jhep.2016.04.016","article-title":"Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: first results of a phase Ib\/IIa study","volume":"65","author":"Bogomolov","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.virol.2015.02.026","article-title":"Interleukin 6 inhibits HBV entry through NTCP down regulation","volume":"481","author":"Bouezzedine","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib17","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/hep.23381","article-title":"MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes","volume":"51","author":"Braconi","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib18","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1006\/viro.1996.0209","article-title":"Myristylation of the large surface protein is required for hepatitis B virus in vitro infectivity","volume":"218","author":"Bruss","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib19","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/sj.cr.7290187","article-title":"LRH-1\/hB1F and HNF1 synergistically up-regulate hepatitis B virus gene transcription and DNA replication","volume":"13","author":"Cai","year":"2003","journal-title":"Cell Res."},{"key":"10.1016\/j.antiviral.2018.08.014_bib20","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1128\/AAC.00473-12","article-title":"Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation","volume":"56","author":"Cai","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.08.014_bib21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.biochem.70.1.369","article-title":"DNA topoisomerases: structure, function, and mechanism","volume":"70","author":"Champoux","year":"2001","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.antiviral.2018.08.014_bib22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0166-0934(88)90020-1","article-title":"Detection of hepatitis B virus DNA in hepatocellular carcinoma: methylation of integrated viral DNA","volume":"19","author":"Chen","year":"1988","journal-title":"J. Virol Meth."},{"key":"10.1016\/j.antiviral.2018.08.014_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002388","article-title":"A kinase chaperones hepatitis B virus capsid assembly and captures capsid dynamics in vitro","volume":"7","author":"Chen","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2018.08.014_bib24","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1096\/fj.11-187781","article-title":"A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication","volume":"25","author":"Chen","year":"2011","journal-title":"Faseb. J."},{"key":"10.1016\/j.antiviral.2018.08.014_bib25","doi-asserted-by":"crossref","first-page":"9021","DOI":"10.1128\/JVI.01261-15","article-title":"Hepatitis B virus covalently closed circular DNA formation in immortalized mouse hepatocytes associated with nucleocapsid destabilization","volume":"89","author":"Cui","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib26","doi-asserted-by":"crossref","first-page":"8124","DOI":"10.1128\/JVI.76.16.8124-8137.2002","article-title":"Identification of SRPK1 and SRPK2 as the major cellular protein kinases phosphorylating hepatitis B virus core protein","volume":"76","author":"Daub","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib27","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nature17170","article-title":"Hepatitis B virus X protein identifies the Smc5\/6 complex as a host restriction factor","volume":"531","author":"Decorsiere","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2018.08.014_bib28","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1002\/hep.29236","article-title":"Polo-like-kinase 1 is a proviral host factor for hepatitis B virus replication","volume":"66","author":"Diab","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib29","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJM199903113401001","article-title":"Rising incidence of hepatocellular carcinoma in the United States","volume":"340","author":"El-Serag","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2018.08.014_bib30","doi-asserted-by":"crossref","first-page":"S488","DOI":"10.1016\/S0168-8278(18)31226-1","article-title":"First clinical evaluation in chronic hepatitis B patients of the synthetic farnesoid X receptor agonist EYP001","volume":"68","author":"Erken","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib31","doi-asserted-by":"crossref","first-page":"18780","DOI":"10.1016\/S0021-9258(17)30580-X","article-title":"Cleavage of disulfide bonds in endocytosed macromolecules. A processing not associated with lysosomes or endosomes","volume":"265","author":"Feener","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2018.08.014_bib32","first-page":"5336","article-title":"Expression of the woodchuck N-myc2 retroposon in brain and in liver tumors is driven by a cryptic N-myc promoter","volume":"12","author":"Fourel","year":"1992","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib33","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1002\/j.1460-2075.1994.tb06542.x","article-title":"Evidence for long-range oncogene activation by hepadnavirus insertion","volume":"13","author":"Fourel","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2018.08.014_bib34","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.1128\/jvi.63.11.4645-4652.1989","article-title":"A recombinant hepatitis B core antigen polypeptide with the protamine-like domain deleted self-assembles into capsid particles but fails to bind nucleic acids","volume":"63","author":"Gallina","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib35","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra031087","article-title":"Hepatitis B virus infection\u2013natural history and clinical consequences","volume":"350","author":"Ganem","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2018.08.014_bib36","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1128\/JVI.02721-06","article-title":"Formation of hepatitis B virus covalently closed circular DNA: removal of genome-linked protein","volume":"81","author":"Gao","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib37","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1006\/viro.1995.0002","article-title":"Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity","volume":"213","author":"Gripon","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.antiviral.2015.08.005","article-title":"Metabolism and function of hepatitis B virus cccDNA: implications for the development of cccDNA-targeting antiviral therapeutics","volume":"122","author":"Guo","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.08.014_bib39","doi-asserted-by":"crossref","first-page":"12472","DOI":"10.1128\/JVI.01123-07","article-title":"Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation","volume":"81","author":"Guo","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib40","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/jmv.21525","article-title":"Evidence that methylation of hepatitis B virus covalently closed circular DNA in liver tissues of patients with chronic hepatitis B modulates HBV replication","volume":"81","author":"Guo","year":"2009","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1128\/JVI.01921-09","article-title":"Production and function of the cytoplasmic deproteinized relaxed circular DNA of hepadnaviruses","volume":"84","author":"Guo","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib42","article-title":"Characterization of the host factors required for hepadnavirus covalently closed circular (ccc) DNA formation","volume":"7","author":"Guo","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2018.08.014_bib43","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1172\/JCI117091","article-title":"Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+\/bile acid cotransporter","volume":"93","author":"Hagenbuch","year":"1994","journal-title":"JCI (J. Clin. Investig.)"},{"key":"10.1016\/j.antiviral.2018.08.014_bib44","first-page":"659","article-title":"Differential activation of myc gene family members in hepatic carcinogenesis by closely related hepatitis B viruses","volume":"13","author":"Hansen","year":"1993","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib45","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1128\/JVI.03094-14","article-title":"Inhibition of hepatitis B virus gene expression and replication by hepatocyte nuclear factor 6","volume":"89","author":"Hao","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib46","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1128\/JVI.72.4.2600-2606.1998","article-title":"Glucagon treatment interferes with an early step of duck hepatitis B virus infection","volume":"72","author":"Hild","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib47","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1002\/hep.29479","article-title":"Epigenetic regulation of hepatitis B virus covalently closed circular DNA: implications for epigenetic therapy against chronic hepatitis B","volume":"66","author":"Hong","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib48","doi-asserted-by":"crossref","first-page":"S319","DOI":"10.1053\/j.gastro.2004.09.047","article-title":"Hepatocellular carcinoma: summary and recommendations","volume":"127","author":"Hoofnagle","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib49","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/hep.21627","article-title":"Management of hepatitis B: summary of a clinical research workshop","volume":"45","author":"Hoofnagle","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib50","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1128\/JVI.76.1.269-279.2002","article-title":"In vitro reconstitution of functional hepadnavirus reverse transcriptase with cellular chaperone proteins","volume":"76","author":"Hu","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib51","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/hep.23660","article-title":"Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1","volume":"52","author":"Huang","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib52","doi-asserted-by":"crossref","first-page":"9443","DOI":"10.1128\/JVI.00873-12","article-title":"Entry of hepatitis B virus into immortalized human primary hepatocytes by clathrin-dependent endocytosis","volume":"86","author":"Huang","year":"2012","journal-title":"J. Virol."},{"issue":"Pt 9","key":"10.1016\/j.antiviral.2018.08.014_bib53","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1099\/0022-1317-79-9-2181","article-title":"Translational regulation of hepatitis B virus polymerase gene by termination-reinitiation of an upstream minicistron in a length-dependent manner","volume":"79","author":"Hwang","year":"1998","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib54","first-page":"1696","article-title":"HBV secretion is regulated through the activation of endocytic and autophagic compartments mediated by Rab7 stimulation","volume":"128","author":"Inoue","year":"2015","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.antiviral.2018.08.014_bib55","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1128\/JVI.02348-08","article-title":"Characterization of genotype-specific carboxyl-terminal cleavage sites of hepatitis B virus e antigen precursor and identification of furin as the candidate enzyme","volume":"83","author":"Ito","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11015-4","article-title":"Functional association of cellular microtubules with viral capsid assembly supports efficient hepatitis B virus replication","volume":"7","author":"Iwamoto","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2018.08.014_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/srep10478","article-title":"Comprehensive DNA methylation analysis of hepatitis B virus genome in infected liver tissues","volume":"5","author":"Jain","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2018.08.014_bib58","series-title":"Nucleic Acid Molecules for Reduction of PAPD5 or PAPD7 mRNA for Treating Hepatitis B Infection","author":"Javanbakht","year":"2017"},{"key":"10.1016\/j.antiviral.2018.08.014_bib59","doi-asserted-by":"crossref","first-page":"11945","DOI":"10.1128\/JVI.01855-15","article-title":"A novel tricyclic polyketide, vanitaracin A, specifically inhibits the entry of hepatitis B and D Viruses by targeting sodium taurocholate cotransporting polypeptide","volume":"89","author":"Kaneko","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib60","doi-asserted-by":"crossref","first-page":"7993","DOI":"10.1128\/jvi.68.12.7993-8000.1994","article-title":"Effect of core protein phosphorylation by protein kinase C on encapsidation of RNA within core particles of hepatitis B virus","volume":"68","author":"Kann","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib61","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1083\/jcb.145.1.45","article-title":"Phosphorylation-dependent binding of hepatitis B virus core particles to the nuclear pore complex","volume":"145","author":"Kann","year":"1999","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib62","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1128\/JVI.72.5.3796-3803.1998","article-title":"Phosphorylation of the core protein of hepatitis B virus by a 46-kilodalton serine kinase","volume":"72","author":"Kau","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib63","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.antiviral.2015.10.004","article-title":"Targeting hepatitis B virus cccDNA using CRISPR\/Cas9","volume":"123","author":"Kennedy","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.08.014_bib64","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/JVI.01232-09","article-title":"Incorporation of eukaryotic translation initiation factor eIF4E into viral nucleocapsids via interaction with hepatitis B virus polymerase","volume":"84","author":"Kim","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib65","first-page":"2425","article-title":"Butyrolactone I, a selective inhibitor of cdk2 and cdc2 kinase","volume":"8","author":"Kitagawa","year":"1993","journal-title":"Oncogene"},{"key":"10.1016\/j.antiviral.2018.08.014_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007124","article-title":"Flap endonuclease 1 is involved in cccDNA formation in the hepatitis B virus","volume":"14","author":"Kitamura","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2018.08.014_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001082","article-title":"Generation of covalently closed circular DNA of hepatitis B viruses via intracellular recycling is regulated in a virus specific manner","volume":"6","author":"Kock","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2018.08.014_bib68","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1111\/jvh.12240","article-title":"Human microRNA hsa-miR-1231 suppresses hepatitis B virus replication by targeting core mRNA","volume":"21","author":"Kohno","year":"2014","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.antiviral.2018.08.014_bib69","doi-asserted-by":"crossref","first-page":"E4244","DOI":"10.1073\/pnas.1409986111","article-title":"Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses","volume":"111","author":"Koniger","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2018.08.014_bib70","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1093\/infdis\/jis273","article-title":"A new class of synthetic peptide inhibitors blocks attachment and entry of human pathogenic viruses","volume":"205","author":"Krepstakies","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.08.014_bib71","doi-asserted-by":"crossref","first-page":"9050","DOI":"10.1128\/JVI.00479-07","article-title":"Hepatitis B virus maturation is sensitive to functional inhibition of ESCRT-III, Vps4, and gamma 2-adaptin","volume":"81","author":"Lambert","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib72","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1006\/viro.1999.9798","article-title":"Roles of the three major phosphorylation sites of hepatitis B virus core protein in viral replication","volume":"259","author":"Lan","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2008.05.007","article-title":"Hepatitis B pregenomic RNA splicing\u2013the products, the regulatory mechanisms and its biological significance","volume":"136","author":"Lee GH","year":"2008","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2018.08.014_bib74","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3350\/cmh.2015.21.3.193","article-title":"From DCPD to NTCP: the long journey towards identifying a functional hepatitis B virus receptor","volume":"21","author":"Li","year":"2015","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib75","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1006\/viro.1995.0046","article-title":"HNF3 binds and activates the second enhancer, ENII, of hepatitis B virus","volume":"214","author":"Li","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001162","article-title":"Nuclear export and import of human hepatitis B virus capsid protein and particles","volume":"6","author":"Li","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2018.08.014_bib77","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1128\/JVI.02627-10","article-title":"Subversion of cellular autophagy machinery by hepatitis B virus for viral envelopment","volume":"85","author":"Li","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004780","article-title":"TGF-beta suppression of HBV RNA through AID-dependent recruitment of an RNA exosome complex","volume":"11","author":"Liang","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2018.08.014_bib79","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/hep.28025","article-title":"Present and future therapies of hepatitis B: from discovery to cure","volume":"62","author":"Liang","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib80","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1080\/15476286.2016.1166330","article-title":"Hepatitis B virus nuclear export elements: RNA stem-loop alpha and beta, key parts of the HBV post-transcriptional regulatory element","volume":"13","author":"Lim","year":"2016","journal-title":"RNA Biol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib81","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0042-6822(03)00403-3","article-title":"Cholesterol requirement of hepatitis B surface antigen (HBsAg) secretion","volume":"314","author":"Lin","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib82","doi-asserted-by":"crossref","first-page":"e186","DOI":"10.1038\/mtna.2014.38","article-title":"The CRISPR\/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo. Molecular therapy","volume":"3","author":"Lin","year":"2014","journal-title":"Nucleic acids"},{"key":"10.1016\/j.antiviral.2018.08.014_bib83","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1053\/j.gastro.2008.10.029","article-title":"MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells","volume":"136","author":"Liu","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003613","article-title":"Alpha-interferon suppresses hepadnavirus transcription by altering epigenetic modification of cccDNA minichromosomes","volume":"9","author":"Liu","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2018.08.014_bib85","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.antiviral.2016.08.026","article-title":"Identification of hydrolyzable tannins (punicalagin, punicalin and geraniin) as novel inhibitors of hepatitis B virus covalently closed circular DNA","volume":"134","author":"Liu","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.08.014_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006296","article-title":"Interferon-inducible ribonuclease ISG20 inhibits hepatitis B virus replication through directly binding to the epsilon stem-loop structure of viral RNA","volume":"13","author":"Liu","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2018.08.014_bib87","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2893.2009.01089.x","article-title":"The correlation of hepatocyte nuclear factor 4 alpha and 3 beta with hepatitis B virus replication in the liver of chronic hepatitis B patients","volume":"16","author":"Long","year":"2009","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.antiviral.2018.08.014_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006784","article-title":"The role of host DNA ligases in hepadnavirus covalently closed circular DNA formation","volume":"13","author":"Long","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2018.08.014_bib89","article-title":"Proteoglycans act as cellular hepatitis delta virus attachment receptors","volume":"8","author":"Longarela","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2018.08.014_bib90","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1073\/pnas.87.13.5069","article-title":"Multiple liver-specific factors bind to the hepatitis B virus core\/pregenomic promoter: trans-activation and repression by CCAAT\/enhancer binding protein","volume":"87","author":"Lopez-Cabrera","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2018.08.014_bib91","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0042-6822(91)91019-D","article-title":"Transcriptional factor C\/EBP binds to and transactivates the enhancer element II of the hepatitis B virus","volume":"183","author":"Lopez-Cabrera","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib92","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1006\/viro.1995.0038","article-title":"Evidence that N-linked glycosylation is necessary for hepatitis B virus secretion","volume":"213","author":"Lu","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib93","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jhep.2011.02.015","article-title":"Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection","volume":"55","author":"Lucifora","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib94","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1126\/science.1243462","article-title":"Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA","volume":"343","author":"Lucifora","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2018.08.014_bib95","doi-asserted-by":"crossref","first-page":"12237","DOI":"10.1128\/JVI.01218-12","article-title":"Cyclin-dependent kinase 2 phosphorylates s\/t-p sites in the hepadnavirus core protein C-terminal domain and is incorporated into viral capsids","volume":"86","author":"Ludgate","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib96","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1128\/JVI.01207-09","article-title":"Hepatitis B virus requires intact caveolin-1 function for productive infection in HepaRG cells","volume":"84","author":"Macovei","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib97","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1128\/JVI.00393-13","article-title":"Regulation of hepatitis B virus infection by Rab5, Rab7, and the endolysosomal compartment","volume":"87","author":"Macovei","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib98","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003494","article-title":"Inhibition of hepatitis B virus replication by the host zinc finger antiviral protein","volume":"9","author":"Mao","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2018.08.014_bib99","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.07.012","article-title":"HBV DNA integration and clonal hepatocyte expansion in chronic hepatitis B patients considered immune tolerant","volume":"151","author":"Mason","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006239","article-title":"Hepatic deficiency of the pioneer transcription factor FoxA restricts hepatitis B virus biosynthesis by the developmental regulation of viral DNA methylation","volume":"13","author":"McFadden","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2018.08.014_bib101","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1073\/pnas.94.5.1822","article-title":"Hepatitis B virus (HBV) envelope glycoproteins vary drastically in their sensitivity to glycan processing: evidence that alteration of a single N-linked glycosylation site can regulate HBV secretion","volume":"94","author":"Mehta","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2018.08.014_bib102","doi-asserted-by":"crossref","first-page":"9810","DOI":"10.1128\/JVI.79.15.9810-9820.2005","article-title":"Hepatitis B virus DNA replication is coordinated by core protein serine phosphorylation and HBx expression","volume":"79","author":"Melegari","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib103","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1073\/pnas.80.9.2534","article-title":"Integrated hepatitis B virus DNA sequences specifying the major viral core polypeptide are methylated in PLC\/PRF\/5 cells","volume":"80","author":"Miller","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2018.08.014_bib104","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11901-011-0113-3","article-title":"Epigenetic regulation of hepatitis B virus infection","volume":"10","author":"Mogul","year":"2011","journal-title":"Curr. Hepat. Rep."},{"key":"10.1016\/j.antiviral.2018.08.014_bib105","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1365-2893.2002.00381.x","article-title":"Regulatory elements of hepatitis B virus transcription","volume":"9","author":"Moolla","year":"2002","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.antiviral.2018.08.014_bib106","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.coviro.2011.05.001","article-title":"Receptors and tropisms of envelope viruses","volume":"1","author":"Morizono","year":"2011","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib107","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.virusres.2017.01.003","article-title":"Advances with using CRISPR\/Cas-mediated gene editing to treat infections with hepatitis B virus and hepatitis C virus","volume":"244","author":"Moyo","year":"2017","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2018.08.014_bib108","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jhep.2017.10.014","article-title":"A novel orally available small molecule that inhibits hepatitis B virus expression","volume":"68","author":"Mueller","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib109","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1016\/j.celrep.2016.08.026","article-title":"Hepatitis B virus X protein promotes degradation of SMC5\/6 to enhance HBV replication","volume":"16","author":"Murphy","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.antiviral.2018.08.014_bib110","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1128\/jvi.66.7.4107-4116.1992","article-title":"The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly","volume":"66","author":"Nassal","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib111","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.virusres.2007.12.024","article-title":"Hepatitis B viruses: reverse transcription a different way","volume":"134","author":"Nassal","year":"2008","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2018.08.014_bib112","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1136\/gutjnl-2015-309809","article-title":"HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B","volume":"64","author":"Nassal","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2018.08.014_bib113","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1128\/jvi.69.6.3350-3357.1995","article-title":"The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes","volume":"69","author":"Newbold","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib114","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1128\/JVI.00465-08","article-title":"Reverse transcriptase- and RNA packaging signal-dependent incorporation of APOBEC3G into hepatitis B virus nucleocapsids","volume":"82","author":"Nguyen","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib115","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1128\/JVI.02510-06","article-title":"Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G","volume":"81","author":"Nguyen","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib116","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/j.gastro.2013.12.024","article-title":"Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes","volume":"146","author":"Ni","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib117","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031952","article-title":"Circulating hepatitis B surface antigen particles carry hepatocellular microRNAs","volume":"7","author":"Novellino","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2018.08.014_bib118","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/hep.27159","article-title":"Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism","volume":"60","author":"Oehler","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib119","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/ng1658","article-title":"Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells","volume":"37","author":"Ohgami","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.antiviral.2018.08.014_bib120","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1128\/jvi.64.9.4578-4581.1990","article-title":"Preferred translation of human hepatitis B virus polymerase from core protein- but not from precore protein-specific transcript","volume":"64","author":"Ou","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib121","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1091\/mbc.01-06-0308","article-title":"Nuclear pore complex is able to transport macromolecules with diameters of about 39 nm","volume":"13","author":"Pante","year":"2002","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.antiviral.2018.08.014_bib122","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1128\/jvi.64.4.1517-1522.1990","article-title":"Transcriptional activation and repression by cellular DNA-binding protein C\/EBP","volume":"64","author":"Pei","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib123","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1128\/JVI.77.3.2287-2294.2003","article-title":"Duck hepatitis B virus virion secretion requires a double-stranded DNA genome","volume":"77","author":"Perlman","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib124","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/j.gastro.2014.10.004","article-title":"Alisporivir inhibition of hepatocyte cyclophilins reduces HBV replication and hepatitis B surface antigen production","volume":"148","author":"Phillips","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib125","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1053\/j.gastro.2006.01.001","article-title":"Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones","volume":"130","author":"Pollicino","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib126","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.dnarep.2014.03.020","article-title":"Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2)","volume":"19","author":"Pommier","year":"2014","journal-title":"DNA Repair"},{"key":"10.1016\/j.antiviral.2018.08.014_bib127","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1093\/nar\/gkr067","article-title":"Human microRNA hsa-miR-125a-5p interferes with expression of hepatitis B virus surface antigen","volume":"39","author":"Potenza","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2018.08.014_bib129","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00430-012-0267-9","article-title":"Host factors involved in hepatitis B virus maturation, assembly, and egress","volume":"201","author":"Prange","year":"2012","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005893","article-title":"DNA polymerase kappa is a key cellular factor for the formation of covalently closed circular DNA of hepatitis B virus","volume":"12","author":"Qi","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2018.08.014_bib131","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10529-011-0751-0","article-title":"NIRF, a novel ubiquitin ligase, interacts with hepatitis B virus core protein and promotes its degradation","volume":"34","author":"Qian","year":"2012","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.antiviral.2018.08.014_bib132","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.bbrc.2010.07.021","article-title":"miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV","volume":"398","author":"Qiu","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2018.08.014_bib133","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2893.2010.01315.x","article-title":"Control of hepatitis B virus at the level of transcription","volume":"17","author":"Quasdorff","year":"2010","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.antiviral.2018.08.014_bib134","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1462-5822.2008.01141.x","article-title":"A concerted action of HNF4alpha and HNF1alpha links hepatitis B virus replication to hepatocyte differentiation","volume":"10","author":"Quasdorff","year":"2008","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib135","series-title":"Lipid-mediated Introduction of Hepatitis B Virus Capsids into Nonsusceptible Cells Allows Highly Efficient Replication and Facilitates the Study of Early Infection Events","author":"Rabe","year":"2006"},{"key":"10.1016\/j.antiviral.2018.08.014_bib136","first-page":"1766","article-title":"Transcription of hepatitis B virus by RNA polymerase II","volume":"3","author":"Rall","year":"1983","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib137","doi-asserted-by":"crossref","DOI":"10.1038\/srep10833","article-title":"CRISPR\/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus","volume":"5","author":"Ramanan","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2018.08.014_bib138","doi-asserted-by":"crossref","first-page":"10832","DOI":"10.1128\/JVI.00883-08","article-title":"Transactivation of the hepatitis B virus core promoter by the nuclear receptor FXRalpha","volume":"82","author":"Ramiere","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib139","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1128\/jvi.65.11.5774-5781.1991","article-title":"Promoter-specific transactivation of hepatitis B virus transcription by a glutamine- and proline-rich domain of hepatocyte nuclear factor 1","volume":"65","author":"Raney","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib140","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S2468-1253(18)30056-6","article-title":"Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study","volume":"3","author":"Razavi-Shearer","year":"2018","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib141","doi-asserted-by":"crossref","DOI":"10.1002\/hep.29912","article-title":"SIRT3 restricts HBV transcription and replication via epigenetic regulation of cccDNA involving SUV39H1 and SETD1A histone methyltransferases","author":"Ren","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib142","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jhep.2015.06.023","article-title":"HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase","volume":"63","author":"Riviere","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib143","doi-asserted-by":"crossref","first-page":"6786","DOI":"10.3748\/wjg.14.6786","article-title":"Dynamic localization of hepatocellular transporters in health and disease","volume":"14","author":"Roma","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib144","doi-asserted-by":"crossref","first-page":"29297","DOI":"10.1074\/jbc.M603517200","article-title":"Gamma-adaptin, a novel ubiquitin-interacting adaptor, and Nedd4 ubiquitin ligase control hepatitis B virus maturation","volume":"281","author":"Rost","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2018.08.014_bib145","doi-asserted-by":"crossref","first-page":"32119","DOI":"10.1074\/jbc.M802632200","article-title":"gamma2-Adaptin, a ubiquitin-interacting adaptor, is a substrate to coupled ubiquitination by the ubiquitin ligase Nedd4 and functions in the endosomal pathway","volume":"283","author":"Rost","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2018.08.014_bib146","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.virol.2007.11.010","article-title":"Hepatitis B virus polymerase suppresses translation of pregenomic RNA via a mechanism involving its interaction with 5' stem-loop structure","volume":"373","author":"Ryu","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib147","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.virol.2010.07.005","article-title":"Proximity between the cap and 5' epsilon stem-loop structure is critical for the suppression of pgRNA translation by the hepatitis B viral polymerase","volume":"406","author":"Ryu","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib148","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000741","article-title":"Nucleoporin 153 arrests the nuclear import of hepatitis B virus capsids in the nuclear basket","volume":"6","author":"Schmitz","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2018.08.014_bib149","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: a complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib150","doi-asserted-by":"crossref","DOI":"10.3390\/v9050125","article-title":"A role for the host DNA damage response in hepatitis B virus cccDNA formation-and beyond?","volume":"9","author":"Schreiner","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2018.08.014_bib151","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/hep.21896","article-title":"Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans","volume":"46","author":"Schulze","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib152","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1128\/MMBR.64.1.51-68.2000","article-title":"Hepatitis B virus biology","volume":"64","author":"Seeger","year":"2000","journal-title":"Microbiol. Mol. Biol. Rev. : MMBR (Microbiol. Mol. Biol. Rev.)"},{"key":"10.1016\/j.antiviral.2018.08.014_bib153","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1038\/mtna.2014.68","article-title":"Targeting hepatitis B virus with CRISPR\/Cas9. Molecular therapy","volume":"3","author":"Seeger","year":"2014","journal-title":"Nucleic acids"},{"key":"10.1016\/j.antiviral.2018.08.014_bib154","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/mt.2016.94","article-title":"Complete spectrum of CRISPR\/Cas9-induced mutations on HBV cccDNA","volume":"24","author":"Seeger","year":"2016","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.antiviral.2018.08.014_bib155","doi-asserted-by":"crossref","first-page":"11751","DOI":"10.1128\/JVI.78.21.11751-11757.2004","article-title":"Translation of duck hepatitis B virus reverse transcriptase by ribosomal shunting","volume":"78","author":"Sen","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib156","doi-asserted-by":"crossref","first-page":"7478","DOI":"10.1128\/JVI.79.12.7478-7491.2005","article-title":"Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity","volume":"79","author":"Shayakhmetov","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib157","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.virol.2010.11.005","article-title":"Heat shock protein 90 facilitates formation of the HBV capsid via interacting with the HBV core protein dimers","volume":"410","author":"Shim","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib158","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jhep.2016.11.009","article-title":"Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity","volume":"66","author":"Shimura","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib159","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1073\/pnas.0911373107","article-title":"The early autophagic pathway is activated by hepatitis B virus and required for viral DNA replication","volume":"107","author":"Sir","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2018.08.014_bib160","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1099\/vir.0.81684-0","article-title":"Negative regulation of hepatitis B virus replication by cellular Hsp40\/DnaJ proteins through destabilization of viral core and X proteins","volume":"87","author":"Sohn","year":"2006","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib161","series-title":"Drug Transporters","first-page":"205","article-title":"The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation","author":"Stieger","year":"2011"},{"key":"10.1016\/j.antiviral.2018.08.014_bib162","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1128\/jvi.63.9.4011-4018.1989","article-title":"Hepatitis B virus transcript produced by RNA splicing","volume":"63","author":"Su","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib163","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/hep.26125","article-title":"A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant","volume":"57","author":"Sureau","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib164","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s00795-009-0480-9","article-title":"Sustained upregulation of sodium taurocholate cotransporting polypeptide and bile salt export pump and downregulation of cholesterol 7alpha-hydroxylase in the liver of patients with end-stage primary biliary cirrhosis","volume":"43","author":"Takeyama","year":"2010","journal-title":"Med. Mol. Morphol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib165","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1073\/pnas.98.4.1841","article-title":"Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism","volume":"98","author":"Tang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2018.08.014_bib166","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1128\/JVI.02555-09","article-title":"Hepatitis B virus (HBV) surface antigen interacts with and promotes cyclophilin a secretion: possible link to pathogenesis of HBV infection","volume":"84","author":"Tian","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib167","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics9040051","article-title":"In vitro phase I metabolism of CRV431, a novel oral drug candidate for chronic hepatitis B","volume":"9","author":"Trepanier","year":"2017","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.antiviral.2018.08.014_bib168","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M114.602540","article-title":"Dysregulation of retinoic acid receptor diminishes hepatocyte permissiveness to hepatitis b virus infection through modulation of sodium taurocholate cotransporting polypeptide (NTCP) expression","volume":"290","author":"Tsukuda","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2018.08.014_bib169","doi-asserted-by":"crossref","DOI":"10.3390\/v9040075","article-title":"HBV DNA integration: molecular mechanisms and clinical implications","volume":"9","author":"Tu","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2018.08.014_bib170","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/hep.28013","article-title":"A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses","volume":"63","author":"Verrier","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib171","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1042\/BJ20120150","article-title":"Ivermectin is a specific inhibitor of importin alpha\/beta-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus","volume":"443","author":"Wagstaff","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.antiviral.2018.08.014_bib172","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1097-2765(00)80348-2","article-title":"Endogenous bile acids are ligands for the nuclear receptor FXR\/BAR","volume":"3","author":"Wang","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.antiviral.2018.08.014_bib173","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1128\/JVI.00011-09","article-title":"DDX3 DEAD-Box RNA helicase inhibits hepatitis B virus reverse transcription by incorporation into nucleocapsids","volume":"83","author":"Wang","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib174","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep.24809","article-title":"Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1) -modulated P53 activity","volume":"55","author":"Wang","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib175","doi-asserted-by":"crossref","first-page":"10205","DOI":"10.1073\/pnas.0704000104","article-title":"Involvement of host cellular multivesicular body functions in hepatitis B virus budding","volume":"104","author":"Watanabe","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2018.08.014_bib176","doi-asserted-by":"crossref","first-page":"31715","DOI":"10.1074\/jbc.M113.501122","article-title":"Interleukin-1 and tumor necrosis factor-alpha trigger restriction of hepatitis B virus infection via a cytidine deaminase activation-induced cytidine deaminase (AID)","volume":"288","author":"Watashi","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2018.08.014_bib177","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/hep.26982","article-title":"Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)","volume":"59","author":"Watashi","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib178","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.1128\/jvi.66.9.5265-5276.1992","article-title":"Hepadnavirus integration: mechanisms of activation of the N-myc2 retrotransposon in woodchuck liver tumors","volume":"66","author":"Wei","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib179","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.cellsig.2013.01.019","article-title":"Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma","volume":"25","author":"Wei","year":"2013","journal-title":"Cell. Signal."},{"key":"10.1016\/j.antiviral.2018.08.014_bib180","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.cellsig.2012.10.013","article-title":"miR-101 is down-regulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A","volume":"25","author":"Wei","year":"2013","journal-title":"Cell. Signal."},{"key":"10.1016\/j.antiviral.2018.08.014_bib181","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/JVI.72.1.778-782.1998","article-title":"Role for calnexin and N-linked glycosylation in the assembly and secretion of hepatitis B virus middle envelope protein particles","volume":"72","author":"Werr","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib182","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1462-5822.2010.01444.x","article-title":"Inhibition of protein kinase C phosphorylation of hepatitis B virus capsids inhibits virion formation and causes intracellular capsid accumulation","volume":"12","author":"Wittkop","year":"2010","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib183","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan0241","article-title":"RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg","volume":"9","author":"Wooddell","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2018.08.014_bib184","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1074\/jbc.M114.601203","article-title":"Decreased expression of hepatocyte nuclear factor 4alpha (Hnf4alpha)\/microRNA-122 (miR-122) axis in hepatitis B virus-associated hepatocellular carcinoma enhances potential oncogenic GALNT10 protein activity","volume":"290","author":"Wu","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2018.08.014_bib185","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.gastro.2015.09.026","article-title":"Interferon-gamma and tumor necrosis factor-alpha Produced by T Cells reduce the HBV persistence form, cccDNA, without cytolysis","volume":"150","author":"Xia","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib186","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"eLife"},{"key":"10.1016\/j.antiviral.2018.08.014_bib187","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1128\/JVI.03478-13","article-title":"Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide","volume":"88","author":"Yan","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib188","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1128\/jvi.69.7.4029-4036.1995","article-title":"Illegitimate replication of linear hepadnavirus DNA through nonhomologous recombination","volume":"69","author":"Yang","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib189","doi-asserted-by":"crossref","first-page":"8710","DOI":"10.1128\/JVI.72.11.8710-8717.1998","article-title":"Infection of ducklings with virus particles containing linear double-stranded duck hepatitis B virus DNA: illegitimate replication and reversion","volume":"72","author":"Yang","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib190","doi-asserted-by":"crossref","first-page":"9710","DOI":"10.1128\/JVI.73.12.9710-9717.1999","article-title":"Integration of hepadnavirus DNA in infected liver: evidence for a linear precursor","volume":"73","author":"Yang","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.08.014_bib191","article-title":"Nuclear export of human hepatitis B virus core protein and pregenomic RNA depends on the cellular NXF1-p15 machinery","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2018.08.014_bib192","doi-asserted-by":"crossref","first-page":"8526","DOI":"10.1073\/pnas.0609883104","article-title":"Unique antiviral mechanism discovered in anti-hepatitis B virus research with a natural product analogue","volume":"104","author":"Ying","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2018.08.014_bib193","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/hep.23008","article-title":"Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression","volume":"50","author":"Zhang","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib194","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.antiviral.2010.08.008","article-title":"Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210","volume":"88","author":"Zhang","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.08.014_bib195","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/hep.24195","article-title":"Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA-1","volume":"53","author":"Zhang","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib196","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fgene.2013.00202","article-title":"Regulation of hepatitis B virus replication by epigenetic mechanisms and microRNAs","volume":"4","author":"Zhang","year":"2013","journal-title":"Front. Genet."},{"key":"10.1016\/j.antiviral.2018.08.014_bib197","article-title":"Transcription of hepatitis B virus covalently closed circular DNA is regulated by CpG methylation during chronic infection","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2018.08.014_bib198","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/hep.29133","article-title":"PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation","volume":"66","author":"Zhang","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2018.08.014_bib199","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.antiviral.2017.11.009","article-title":"HBsAg mRNA degradation induced by a dihydroquinolizinone compound depends on the HBV posttranscriptional regulatory element","volume":"149","author":"Zhou","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.08.014_bib200","doi-asserted-by":"crossref","first-page":"9556","DOI":"10.1073\/pnas.94.18.9556","article-title":"Localization of the C terminus of the assembly domain of hepatitis B virus capsid protein: implications for morphogenesis and organization of encapsidated RNA","volume":"94","author":"Zlotnick","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2018.08.014_bib201","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2009.08.063","article-title":"Hepatitis B virus resistance to nucleos(t)ide analogues","volume":"137","author":"Zoulim","year":"2009","journal-title":"Gastroenterology"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218303656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218303656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:29:36Z","timestamp":1759062576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354218303656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":202,"alternative-id":["S0166354218303656"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.08.014","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Host functions used by hepatitis B virus to complete its life cycle: Implications for developing host-targeting agents to treat chronic hepatitis B","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}